Clinical Trials
14
Active:1
Completed:7
Trial Phases
2 Phases
Phase 1:13
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials
Phase 1
13 (92.9%)Phase 3
1 (7.1%)Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female Volunteers
Phase 1
Not yet recruiting
- Conditions
- Healthy Postmenopausal Women
- Interventions
- First Posted Date
- 2025-05-29
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- Kashiv BioSciences, LLC
- Target Recruit Count
- 40
- Registration Number
- NCT06995482
- Locations
- 🇺🇸
Floridian Clinical Research LLC, Miami Lakes, Florida, United States
🇮🇳Synergen Bio Pvt. Ltd., Pune, Maharashtra, India
Open Label , Randomized, Three Arm Parallel Group Single Dose Comparative Pharmacokinetic , Safety and Immunogenicity Study in Healthy Subjects
- First Posted Date
- 2025-04-15
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- Kashiv BioSciences, LLC
- Target Recruit Count
- 300
- Registration Number
- NCT06929039
- Locations
- 🇨🇦
Not Disclosed, Missisauga, Canada
A Open Label ,Randomized, Balanced, Two-treatment, Single Period, Parallel, Comparative Pharmacokinetic Study in Healthy Subjects
Phase 1
Recruiting
- Conditions
- Chronic Idiopathic Urticaria
- Interventions
- Device: ADL-018 AutoinjectorDrug: ADL-018 Injection
- First Posted Date
- 2025-04-15
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- Kashiv BioSciences, LLC
- Target Recruit Count
- 150
- Registration Number
- NCT06929052
- Locations
- 🇨🇦
Not Disclosed, Missisauga, Canada
Open Label Randomized Comparative Crossover Pharmacokinetic and Immunogenicity Study
Phase 1
Active, not recruiting
- Conditions
- Febrile Neutropenia
- Interventions
- Device: TPI-120 with On body injectorDrug: Fylntera
- First Posted Date
- 2025-04-09
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- Kashiv BioSciences, LLC
- Target Recruit Count
- 180
- Registration Number
- NCT06918587
- Locations
- 🇯🇴
Not Disclosed, Jordan, Jordan
Open Label, Sequential Dosing , Single Ascending Dose and Multiple Dose Safety Tolerability and Pharmacokinetic Study
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Kashiv BioSciences, LLC
- Target Recruit Count
- 48
- Registration Number
- NCT06074757
- Locations
- 🇯🇴
Triumpharma Cro, Amman, Jordan
- Prev
- 1
- 2
- Next
News
No news found